top of page
GC-MS autosampler_edited.jpg

Our research lies at the interface of synthetic organic chemistry and medicinal chemistry. We develop new molecules and synthetic strategies for biologically relevant problems, with emphasis on structural innovation, mechanistic insight, and experimental precision. Current efforts span neuropharmacology, cannabinoid chemistry, psychedelic-inspired compounds, antibacterial discovery, and reaction development.

Synthetic Neuropharmacology

We design and synthesize structurally distinctive small molecules for targets relevant to nervous-system function. Our work focuses on molecular frameworks that modulate neuronal signaling and probe neurobiological function. Particular emphasis is placed on precise structural control, functional readout, and the translation of chemical architecture into measurable biological effect.

dimatsv_Picasso-style_4k_image_of_the_hu
dimatsv_cannabis_realm_edited.jpg

Cannabinoid Chemistry

We investigate the chemistry of cannabinoids and structurally related analogues to access new cannabinoid-based molecular architectures. This work combines synthesis, scaffold variation, and functional-group control to generate molecules with altered topology, reactivity, and biological profile. Emphasis is placed on chemically rigorous routes to structurally distinct cannabinoid-derived compounds.

Psychedelic-Inspired Molecular Design

0_3.png

We synthesize new small molecules guided by structural motifs associated with psychedelic and related neuroactive compounds. The work focuses on chemically distinct structures of interest in neuropharmacological research. Emphasis is placed on synthetic originality, structural clarity, and biological relevance.

Antibacterial Drug Discovery

We pursue chemically innovative strategies for the design and synthesis of new antibacterial agents. Our work emphasizes structurally original compounds and hybrid design concepts with the potential to access new functional profiles. This program is guided by the need for new antibacterial chemotypes and by the broader challenge of overcoming resistance through molecular innovation.

bacteria.jpg

Reaction Development and Synthetic Methods

Chemistry - Lab Worker.jpg
fullsizeoutput_244.jpeg
Pharmaceutical production line. Vaccine
Reaction in progress in organic chemistr
fullsizeoutput_225.jpeg

A central part of our research is the discovery of new synthetic transformations and unusual modes of reactivity. We are particularly interested in reactions that reveal underexplored behavior in familiar functional groups, open access to valuable molecular architectures, or challenge conventional mechanistic expectations. In our group, methodology is not only a tool for synthesis, but also a source of new chemical understanding.

bottom of page